Core biopsy revealed invasive ductal carcinoma Grade 2, estrogen receptor (ER)/progesterone receptor (PR) positive, human epidermal growth factor receptor 2 (HER2) negative, with high Ki67, consistent with luminal B type (Figure 4). This evidence concerns the gene PGR and invasive ductal breast carcinoma.